Interaction Details

There were no interactions found between Bevacizumab and Alpha-linolenic Acid (ala). This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about combining Bevacizumab and Alpha-linolenic Acid (ala)? Ask Dr. Brian Staiger about it by contacting him directly.

Alpha-linolenic Acid (ala) Overview

Alpha-linolenic acid (ALA) is an essential omega-3 fatty acid. It is primarily found in vegetable oils like flaxseed, canola, and soybean oils, as well as in red meat, dairy products, margarines, and salad dressings containing vegetable oils. Walnuts and other edible nuts are also significant sources of ALA, along with smaller amounts in green leafy vegetables and chocolate. ALA is present in human breast milk, infant formulas, and intravenous fat emulsions. The body converts ALA into longer and more unsaturated omega-3 fatty acids, such as EPA and DHA, with conversion rates typically low but possibly as high as 30%. However, in some disease states like type 1 diabetes, chronic alcoholism, and schizophrenia, the conversion of ALA to longer-chain fatty acids is reduced, though the reason for this remains unknown. R-ALA, or R-alpha-linolenic acid, is a specific form of alpha-linolenic acid (ALA) that occurs naturally in foods. Unlike ALA, which encompasses both R-ALA and S-ALA forms, R-ALA is the biologically active isomer that is more readily absorbed and utilized by the body.
See More Information Regarding Alpha-linolenic Acid (ala)

Bevacizumab Overview

  • Bevacizumab injection products are used in combination with other chemotherapy medications to treat certain types of colon and rectal cancer (cancer that begins in the large intestine), non-small cell lung cancer (NSCLC), glioblastoma (a certain type of cancerous brain tumor), renal cell cancer (RCC, a type of cancer that begins in the kidney), cervical cancer (cancer that begins in the opening of the uterus [womb]), and ovarian (female reproductive organs where eggs are formed), fallopian tube (tube that transports eggs released by the ovaries to the uterus), or peritoneal (layer of tissue that lines the abdomen) cancer. Bevacizumab (Avastin) is also used in combination with atezolizumab (Tecentriq) to treat hepatocellular carcinoma (HCC) that has spread or cannot be removed by surgery in people who have not previously received chemotherapy. Bevacizumab injection products are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumors. This may slow the growth and spread of tumors.

See More Information Regarding Bevacizumab Injection

Alpha-linolenic Acid (ala) - More Interactions

Alpha-linolenic Acid (ala) interacts with 0 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.

Major The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur.
Moderate Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur.
Minor Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction.
Unknown No interactions have been reported or no interaction data is currently available.

Return to the main herbal interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.

Ask A Pharmacist About Your Herbal Questions!

Dr. Brian Staiger, PharmD

In addition to being a clinical pharmacist specializing in pharmacotherapy, Dr. Brian Staiger is a registered herbalist through the American Herbalist Guild. He has combined his passion for pharmacy practice with the study of medical ethnobotany to improve patient care. Feel free to reach out about any of your herbal or medication questions!

Ask A Pharmacist